Home » Siemens Embedded Multivariate Analysis Engine Features Umetrics Technology for PAT Solutions
Siemens Embedded Multivariate Analysis Engine Features Umetrics Technology for PAT Solutions
PharmaManufacturing.com
02/09/2010
Umetrics, a world leader in multivariate data analysis (MVDA) software, announces SIEMENS SIPAT, featuring embedded Umetrics MVDA for the implementation of Process Analytical Technology (PAT). SIPAT improves process understanding and, by permitting a focus on either specific units or total batch quality, its advanced process control allows continuous process improvement in both manufacturing and development applications, enabling real-time product release.
Umetrics’ SIMCA product family is tightly integrated and connected into the SIPAT environment, from model building and management of MVDA models through to the real-time application of these models. The use of MVDA models is enabled by the incorporation of SIMCA-Q, a calculation engine for real-time multivariate predictions of continuous and batch process results. Also, SIMCA-Batch On-Line (SBOL), a server – client MVDA solution, is interfaced with the SIPAT system.
These real-time quality assurance and fault detection solutions provide substantial cost-savings and improved product quality and process economics.
SIMCA-Q is the calculation engine of the SIMCA-suite of off-line and on-line software. This suite is used in research, development, and manufacturing for a variety of objectives and purposes all with one common goal; value from data. This platform makes the analysis efficient and easily interpretable, further enhanced by Umetrics’ expertise, training and constructive support.
For more information about SIPAT, please email info.sipat@siemens.com or visit www.siemens.com/sipat.
More News:
-
05/24/2013
Merck Stops Development of Parkinson’s DrugFrom Bloomberg
Merck & Co. will end development of preladenant because a preliminary review of late-stage clinical trials suggests it doesn’t work
-
05/23/2013
French Drugmaker on Trial for Suspected DeathsFrom Yahoo! News
Servier Laboratories, French drugmaker responsible for producing diabetes and weight loss drug Mediator, faces charges for deception in relation to the suspected deaths of hundreds of people.
-
05/22/2013
Novo Acquires Xellia Pharmaceuticals for $700 MillionFrom PharmaTimes Online
Novo A/S has acquired Xellia Pharmaceuticals of Norway
-
05/22/2013
Royalty Increases Bid as Elan Unveils AcquisitionsFrom PharmaTimes Online
Royalty Pharma has resurfaced to raise its bid to acquire the Irish drugmaker Elan
-
05/22/2013
New Asthma Drug Offers Hope for PatientsFrom Forbes
An experimental asthma drug could give new hope to patients for whom existing medicines are not enough
-
05/21/2013
Syrian Pharma Production Nearly Halted by WarFrom AFP
A shortage of foreign currency has brought production to a near halt in Syria
-
05/21/2013
Camfil APC Opens Manufacturing Plant in the UKFrom Camfil
Camfil announced the grand opening of its new 40,000-sq.-ft. facility
-
05/21/2013
Actavis Acquiring Warner Chilcott for $8.5BFrom AP
Actavis to buy Warner Chilcott in an all-stock transaction
-
05/17/2013
Northwest Analytics Launches Next Generation Enterprise Manufacturing Intelligence SolutionFrom Northwest Analytics
NWA Focus EMI Delivers Real Time Process Intelligence and Unique Accelerating Modules - a Shared Knowledge Base and Manufacturing-Centric Collaboration
-
05/16/2013
Innovative Clinical Development Partnership Announced By Quintiles and Merck SeronoFrom MarketWatch.com
Agreement creates unique strategic collaboration for development and clinical trial execution
- All news »
Get Connected Now!
- Featured White Papers

Print page